Viscosupplementation Market Size By Product (Single Injection, 3 Injections, 5 Injections), By Source of Origin (Avian Origin, Non-avian Origin), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Industry Trends

Viscosupplementation Market size was valued at over USD 2.7 billion in 2019 and is projected to grow at a CAGR of 10.1% between 2020 and 2026.
 

Get more details on this report - Request Free Sample PDF

Viscosupplementation is a minimally invasive technique for the people suffering from osteoarthritis. Viscosupplementation is a procedure that includes injection of hyaluronic acid into the knee joint of an individual. Hyaluronic acid is a naturally occurring lubricating substance that is found in high concentration in fluids in the joints and eyes. This fluid play a vital role in reducing pain and swelling in arthritic joints such as knee.
 

Growing geriatric population susceptible to osteoarthritis will boost the market growth during the forecast period. According to a recently published data by the Centers for Disease Control and Prevention (CDC), osteoarthritis affects over 32.5 million adults in the U.S. on an annual basis. Such large patient pool will require medical treatment to reduce the pain, stiffness and swelling caused by osteoarthritis and will ultimately generate the market expansion in the coming years.
 

Increasing demand for minimally invasive viscosupplementation procedures for the treatment of osteoarthritis will enhance the industry growth. The minimally invasive treatment replaces synovial fluid by intra-articular injection of hyaluronic acid. As the cost of minimally invasive procedures is significantly less than the conventional procedures, the market will witness considerable growth during the forecast timeframe.
 

Increasing prevalence of osteoarthritis coupled with new product launches will drive the viscosupplementation market value

The single injection regimen provides greater physician and patient convenience and hence, is highly preferred over other treatments for viscosupplementation. Osteoarthritis is not only limited to pain and reduced quality of life for patients but also generates high and extra hospital costs. Owing to the rapidly increasing patients suffering from osteoarthritis, the market players will focus on providing single injection viscosupplementation treatments. Moreover, viscosupplementation is a cost-effective treatment option to delay total knee replacement surgery. Hence, low-income countries will majorly focus on viscosupplementation thereby, spurring the market demand. Additionally, launch of new products for the treatment of osteoarthritis will contribute to the industry expansion in the coming years.

Presence of large number of commercialized products for the treatment of osteoarthritis will foster the segment growth

The 3 injections segment captured around 48% of the market share in 2019. The 3 injection viscosupplementation treatments are in the market for quite a long time. The segment expansion is attributed to the factors such as high adoption of products and presence of large number of commercialized products for the treatment of osteoarthritis. The viscosupplementation procedure with the help of 3 injections is provided to the patients at weekly intervals. The 3 injections treatment reduces the pain of an individual within few weeks and hence, will ultimately enhance the product demand.

 

Several advantages of viscosupplements with non-avian origin will impel the segment value

The non-avian origin segment accounted for USD 2.1 billion in 2019. The viscosupplements with non-avian origin are the bio-fermentation products produced using bacteria. Due to the high safety, effectiveness and lower allergenic potential, large number of patients are selecting the viscosupplementation procedures with non-avian source of origin. In addition, the hyaluronic acid derived from non-avian origin reduces the risks of adverse reactions such as arthralgia, injection-site erythema, swelling, joint warmth and joint effusion.
 

Rising number of hospitals across the globe will contribute to the growth of viscosupplementation market

Get more details on this report - Request Free Sample PDF
 

The hospitals end-use segment is anticipated to expand at 9.8% growth rate through 2026. Increasing number of hospitals across the globe and availability of appropriate viscosupplementation procedures for the patients suffering from osteoarthritis will positively impact the segment progression.
 

Strong presence of market players and increasing incidence of osteoarthritis across the region will create growth opportunities for the U.S. region

Get more details on this report - Request Free Sample PDF

U.S. viscosupplementation market size was over USD 1.2 billion in 2019 on account of the increasing number of patients suffering from osteoarthritis and growing elderly population. Moreover, strong presence of the market leaders offering hyaluronic acid will significantly contribute to the industry demand. For instance, Anika Therapeutics is one of the leading U.S. manufacturers that provides hyaluronic acid-based products for a broad range of therapeutic applications. Thus, such companies will boost the market revenue across the country. Furthermore, rise in the number of healthcare professionals as well as healthcare facilities will prove beneficial for the treatment of people having degenerative joint.
 

France market is estimated to expand at a CAGR of 10% by 2026 owing to the high incidence of osteoarthritis in French population. For instance, as per the recent news article, in 2016, more than 10 million people in France suffered from osteoarthritis. Thus, the large population of osteoarthritis patients will require viscosupplementation procedures for their treatment and will ultimately augment the industry progression. In addition, strong focus on improving healthcare facilities across the country will further contribute to the market growth.
 

Implementation of several strategies such as new product launches and acquisitions by the major industry participants will contribute to the market progression

Some of the prominent companies functioning in the market are Anika Therapeutics, Inc., Aptissen, Bioventus, Chugai Pharmaceutical Co., Ltd, Johnson & Johnson Services, Inc., Mylan Inc., Zimmer Biomet, Wellchem Pharmaceuticals Pte Ltd. and Genzyme Corporation among others. These industry leaders are majorly focusing on various strategies such as mergers, acquisitions, partnerships, new product launches, collaborations and other market development strategies.
 

Recent industry developments:

• In February 2020, Anika Therapeutics, Inc. completed the acquisition of Arthrosurface that is a privately held manufacturer of preservation solutions and joint surface for active patients. The strategic move will increase the customer base of company thereby, driving the industry revenue.  
   
• In March 2018, Bioventus launched its single injection, hyaluronic acid product in the U.S. market. The strategy helped the company in increasing its geographic presence thereby, fueling the market growth. 
      

The viscosupplementation market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

Market, By Product, 2015 – 2026 (USD Million)

• Single Injection
• 3 Injections
• 5 Injections

Market, By Source of Origin, 2015 – 2026 (USD Million)

• Avian Origin
• Non-avian Origin

Market, By End-use, 2015 – 2026 (USD Million)

• Hospitals
• Ambulatory Surgical Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE